Royalty Pharma plc
DE ˙ MUN ˙ GB00BMVP7Y09
46,92 € ↑0,92 (2,01%)
2026-06-04
DEL PRIS
SecurityDE:RPD / Royalty Pharma plc
InstitutionAviva Plc
Latest Disclosed Ownership323,823 shares
Latest Disclosed Value $ 15,533,789
Aviva Plc reports 2.78% increase in ownership of RPD / Royalty Pharma plc

On May 14, 2026 - Aviva Plc filed a 13F-HR form disclosing ownership of 323,823 shares of Royalty Pharma plc (DE:RPD) valued at $12,975,588 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 315,074 shares of Royalty Pharma plc. This represents a change in shares of 2.78% during the quarter. The current value of the position is $15,195,394 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 323,823 8,749 2.78 15,534 27.59 0.0261
2026-02-12 2025-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 315,074 16,741 5.61 12,174 15.67 0.0205
2025-11-13 2025-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 298,333 17,754 6.33 10,525 4.12 0.0191
2025-08-07 2025-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 280,579 17,377 6.60 10,109 23.39 0.0209
2025-05-15 2025-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 263,202 34,133 14.90 8,193 40.22 0.0198
2025-02-13 2024-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 229,069 214,946 1,521.96 5,844 1,364.41 0.0152
2024-11-14 2024-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 14,123 -48 -0.34 400 6.97 0.0010
2024-08-02 2024-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 14,171 0 0.00 374 -13.26 0.0010
2024-05-14 2024-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 14,171 177 1.26 430 9.41 0.0014
2024-02-09 2023-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 13,994 0 0.00 393 3.69 0.0014
2023-11-13 2023-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 13,994 -53 -0.38 380 -12.06 0.0016
2023-08-10 2023-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 14,047 -4,983 -26.18 432 -37.08 0.0018
2023-05-12 2023-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 19,030 -30,939 -61.92 686 -65.30 0.0031
2023-02-14 2022-12-31 13F/A-2 ROYALTY PHARMA SHS CLASS A G7709Q104 49,969 -1,048 -2.05 1,975 -3.71 0.0097
2023-02-10 2022-12-31 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 49,969 -1,048 970 0.0046
2023-02-09 2022-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 49,969 -1,048 2 0.0095
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 51,017 -24,109 -32.09 2,050 -35.09 0.0118
2022-08-04 2022-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 75,126 -8,223 -9.87 3,158 -2.74 0.0168
2022-05-13 2022-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 83,349 32,894 65.19 3,247 61.46 0.0162
2022-02-10 2021-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 50,455 -4,952 -8.94 2,011 0.45 0.0084
2021-11-12 2021-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 55,407 -48,472 -46.66 2,002 -52.98 0.0089
2021-08-10 2021-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 103,879 1,560 1.52 4,258 -4.59 0.0187
2021-05-13 2021-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 102,319 68,469 202.27 4,463 163.46 0.0218
2021-02-10 2020-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 33,850 33,850 1,694 0.0088
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.